1. Home
  2. ELVN vs SBR Comparison

ELVN vs SBR Comparison

Compare ELVN & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • SBR
  • Stock Information
  • Founded
  • ELVN 2016
  • SBR 1982
  • Country
  • ELVN United States
  • SBR United States
  • Employees
  • ELVN N/A
  • SBR N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • SBR Oil & Gas Production
  • Sector
  • ELVN Health Care
  • SBR Energy
  • Exchange
  • ELVN Nasdaq
  • SBR Nasdaq
  • Market Cap
  • ELVN 1.2B
  • SBR 1.1B
  • IPO Year
  • ELVN 2020
  • SBR N/A
  • Fundamental
  • Price
  • ELVN $19.02
  • SBR $77.03
  • Analyst Decision
  • ELVN Strong Buy
  • SBR
  • Analyst Count
  • ELVN 5
  • SBR 0
  • Target Price
  • ELVN $41.20
  • SBR N/A
  • AVG Volume (30 Days)
  • ELVN 489.5K
  • SBR 45.2K
  • Earning Date
  • ELVN 11-12-2025
  • SBR 01-01-0001
  • Dividend Yield
  • ELVN N/A
  • SBR 7.13%
  • EPS Growth
  • ELVN N/A
  • SBR N/A
  • EPS
  • ELVN N/A
  • SBR 5.05
  • Revenue
  • ELVN N/A
  • SBR $77,682,730.00
  • Revenue This Year
  • ELVN N/A
  • SBR N/A
  • Revenue Next Year
  • ELVN $20.05
  • SBR N/A
  • P/E Ratio
  • ELVN N/A
  • SBR $15.17
  • Revenue Growth
  • ELVN N/A
  • SBR N/A
  • 52 Week Low
  • ELVN $13.30
  • SBR $58.25
  • 52 Week High
  • ELVN $30.03
  • SBR $77.49
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 44.06
  • SBR 67.30
  • Support Level
  • ELVN $18.01
  • SBR $76.00
  • Resistance Level
  • ELVN $20.30
  • SBR $76.52
  • Average True Range (ATR)
  • ELVN 1.11
  • SBR 1.33
  • MACD
  • ELVN -0.16
  • SBR 0.03
  • Stochastic Oscillator
  • ELVN 30.70
  • SBR 91.22

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

Share on Social Networks: